Taiwan FDA registration 58e066dca616be1703cbc28fbe1439ea
"Baxter" hemocoagulant hemostatic agent
TW: “百特”伏血凝止血劑
Taiwan·Risk Class 3·BAXTER HEALTHCARE CORPORATION·Registered Sep 22, 2009 – Sep 22, 2029ActiveRegistration details
- Analysis ID
- 58e066dca616be1703cbc28fbe1439ea
- Customs Code
- DHA00602037706
Company information
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- BAXTER HEALTHCARE LTD.
Product details
- Intended Use
- In addition to ophthalmic surgery, hemostatic agents may be used as hemostatic aids during surgery when ligation or traditional hemostasis are not feasible.
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.4490 Absorbable hemostats and dressings
- Import Information
- import
Dates and status
- Registration Date
- Sep 22, 2009
- Expiry Date
- Sep 22, 2029
About this record
Access comprehensive regulatory information for "Baxter" hemocoagulant hemostatic agent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 58e066dca616be1703cbc28fbe1439ea and manufactured by BAXTER HEALTHCARE CORPORATION. The authorized representative in Taiwan is BAXTER HEALTHCARE LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices